Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05289310 · ClinicalTrials.gov registry record · NA

Low Oxygen Exposure and Weight Status

A NA study of Obesity, sponsored by Pennington Biomedical Research Center.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05289310 is a NA study of Obesity that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 60 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05289310, a NA study of Obesity, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The objective of the proposed double-blind, parallel-arm, randomized clinical trial is to evaluate changes in body weight and composition, assess determinants of energy balance (intake and expenditure), and measure modulators of energy balance, following 8 wk of calorie restriction (-500 kcal/d) in combination with either overnight exposure to normobaric hypoxia (8 h/night, 15% FiO2, \~2640 m) or normoxia (8 h/night, 21% FiO2), using a commercially available, in-home tent system, in adults with obesity.

Conditions Studied

Interventions

  • OTHER Normobaric hypoxia (NH)
  • OTHER Normobaric normoxia (NN)

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-05-16
Est. Completion 2027-04-30
Phase NA

What the Registry Record Tells You About NCT05289310

The ClinicalTrials.gov registry entry for NCT05289310 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Normobaric hypoxia (NH) is the first listed.

NCT05289310 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT05289310 about?

NCT05289310 is a clinical study titled "Low Oxygen Exposure and Weight Status". The objective of the proposed double-blind, parallel-arm, randomized clinical trial is to evaluate changes in body weight and composition, assess determinants of energy balance (intake and expenditure), and measure modulators of energy balance, following 8 wk of calorie restriction (-500 kcal/d) in ...

What is the current status of trial NCT05289310?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-05-16. Estimated completion is 2027-04-30.

What conditions does trial NCT05289310 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT05289310?

The interventions under investigation include: Normobaric hypoxia (NH) (OTHER), Normobaric normoxia (NN) (OTHER).

Who is sponsoring clinical trial NCT05289310?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05289310 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.